| abstract |
The present invention relates to a composition for cancer prevention or treatment, using maturation induction of immature dendritic cells, and particularly to a composition for cancer prevention or treatment, using the Weissella cibaria strain LBML2 (accession number: KCCM12948P) so as to mature immature dendritic cells, thereby enabling the immune response of T lymphocytes to cancer cells to be induced. A composition comprising, as an active ingredient, dendritic cells matured using a microorganism, according to the present invention, exhibits excellent anticancer activity in an animal model, and as such may be effectively used as a composition for uses such as cancer treatment, prevention, or alleviation in humans or animals. |